These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34860629)

  • 1. Biological therapies in patients with liver disease: are they really lifesavers?
    Vitale G; Gitto S; Campani C; Turco L; Baldan A; Marra F; Morelli MC
    Expert Opin Biol Ther; 2022 Apr; 22(4):473-490. PubMed ID: 34860629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease.
    Horst AK; Kumashie KG; Neumann K; Diehl L; Tiegs G
    Cell Mol Immunol; 2021 Jan; 18(1):92-111. PubMed ID: 33110250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research advances of autoimmune liver diseases in 2018].
    Chen Y; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):14-17. PubMed ID: 30685918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of biologics in the treatment of autoimmune liver disease.
    Chang C; Tanaka A; Bowlus C; Gershwin ME
    Expert Opin Investig Drugs; 2020 Apr; 29(4):385-398. PubMed ID: 32102572
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases.
    Richardson N; Ng STH; Wraith DC
    Front Immunol; 2020; 11():1586. PubMed ID: 32793226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
    Bansi D; Chapman R; Fleming K
    J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
    Kemme S; Mack CL
    Pediatr Clin North Am; 2021 Dec; 68(6):1293-1307. PubMed ID: 34736590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in autoimmune liver diseases.
    Manns MP
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S256-71. PubMed ID: 9407346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geoepidemiology of autoimmune liver diseases.
    Invernizzi P
    J Autoimmun; 2010 May; 34(3):J300-6. PubMed ID: 20036105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ.
    Invernizzi P
    J Autoimmun; 2013 Oct; 46():1-6. PubMed ID: 24012346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune liver diseases].
    Pannicke N; Schramm C; Lohse AW
    Internist (Berl); 2012 Aug; 53(8):943-54; quiz 955-6. PubMed ID: 22806149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet challenges in immune-mediated hepatobiliary diseases.
    Beuers U; Gershwin ME
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):127-31. PubMed ID: 25820618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune liver diseases.
    Invernizzi P; Mackay IR
    World J Gastroenterol; 2008 Jun; 14(21):3290-1. PubMed ID: 18528925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune diseases of the liver.
    Manns MP
    Clin Lab Med; 1992 Mar; 12(1):25-40. PubMed ID: 1563239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research advances in autoimmune liver diseases in 2016].
    Li B; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):100-104. PubMed ID: 28297794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases.
    Herkel J
    Dig Dis; 2015; 33 Suppl 2():70-4. PubMed ID: 26642346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.
    Cargill T; Culver EL
    Front Immunol; 2021; 12():661196. PubMed ID: 33936097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
    World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4-related disease of the hepatobiliary tract : 2 case reports and review of the literature.
    Spapen J; Reekmans A; Berghmans B; Debeuckelaere S; Buydens P; Trappeniers L; Van den Bossche B; Colle I
    Acta Gastroenterol Belg; 2018; 81(1):83-87. PubMed ID: 29562380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers.
    Kremer AE; Rust C; Eichhorn P; Beuers U; Holdenrieder S
    Expert Rev Mol Diagn; 2009 Mar; 9(2):139-56. PubMed ID: 19298138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.